Curtis L Cooper
Overview
Explore the profile of Curtis L Cooper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
1425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taher M, Salzman T, Banal A, Morissette K, Domingo F, Cheung A, et al.
Health Promot Chronic Dis Prev Can
. 2025 Mar;
45(3):112-138.
PMID: 40073162
Introduction: We investigated the prevalence of new or persistent manifestations experienced by COVID-19 survivors at 3 or more months after their initial infection, collectively known as post-COVID-19 condition (PCC). Methods:...
2.
Lu J, Vulesevic B, Burchell A, Singer J, Needham J, Yang Y, et al.
Vaccine X
. 2024 Nov;
21:100566.
PMID: 39582795
Background: Understanding the roots of vaccine confidence in vulnerable populations, such as persons living with HIV (PLWH), is important to facilitate vaccine uptake, thus mitigating infection and spread of vaccine-preventable...
3.
DSouza M, Keeshan A, Gravel C, Langlois M, Cooper C
NPJ Vaccines
. 2024 Nov;
9(1):226.
PMID: 39557875
Obesity is a recognized factor influencing immune function and infectious disease outcomes. Characterization of the influence of obesity on SARS-CoV-2 humoral vaccine immunogenicity is required to properly tailor vaccine type...
4.
Chambers C, Cooper C, Kroch A, Buchan S, Kendall C, Kwong J, et al.
AIDS
. 2024 Oct;
38(10):1597-1600.
PMID: 39422634
We found that rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and reverse transcriptase (RT)-PCR-confirmed infection were approximately 50% higher in a population-based cohort of people with HIV...
5.
Cuperlovic-Culf M, Bennett S, Galipeau Y, McCluskie P, Arnold C, Bagheri S, et al.
iScience
. 2024 Aug;
27(8):110484.
PMID: 39156648
Prevention of negative COVID-19 infection outcomes is associated with the quality of antibody responses, whose variance by age and sex is poorly understood. Network approaches identified sex and age effects...
6.
Heiskanen A, Galipeau Y, Little J, Langlois M, Cooper C
Immun Inflamm Dis
. 2024 Jul;
12(7):e1342.
PMID: 39023424
Background: Epidemiological data on seasonal coronaviruses (sCoVs) may provide insight on transmission patterns and demographic factors that favor coronaviruses (CoVs) with greater disease severity. This study describes the incidence of...
7.
Li J, Vranjkovic A, Read D, Delaney S, Stanford W, Cooper C, et al.
Front Immunol
. 2024 Jun;
15:1375485.
PMID: 38887299
Background: The impact of chronic hepatic infection on antigen non-specific immune cells in circulation remains poorly understood. We reported lasting global hyperfunction of peripheral CD8 T cells in HCV-infected individuals...
8.
Tandon S, Castaneda R, Tarasco N, Percival J, Nieto Linares R, Geiger G, et al.
Front Public Health
. 2024 Jun;
12:1281079.
PMID: 38832223
Introduction: Many individuals living with hepatitis C virus (HCV) are unaware of their diagnosis and/or have not been linked to programs providing HCV care. The use of electronic medical record...
9.
Costiniuk C, Lee T, Singer J, Galipeau Y, Arnold C, Langlois M, et al.
Vaccines (Basel)
. 2024 May;
12(5).
PMID: 38793698
COVID-19 breakthrough infection (BTI) can occur despite vaccination. Using a multi-centre, prospective, observational Canadian cohort of people with HIV (PWH) receiving ≥2 COVID-19 vaccines, we compared the SARS-CoV-2 spike (S)...
10.
Keeshan A, Fernandes da Silva C, Vachon A, Giles E, Osiowy C, Coffin C, et al.
J Clin Med
. 2023 Nov;
12(21).
PMID: 37959272
HBV is a hepatotropic virus with multiple genotypes. It is uncertain if specific genotype(s) influence virological measures and/or liver markers over time. It is unclear whether nucleos(t)ide analogue therapy response...